Purpose This study reviewed the current literature examining the potential relationship
between use of antidepressants during pregnancy and attention-deficit/hyperactivity …

Aims To investigate whether exposure to antipsychotic medications during pregnancy is
associated with gestational diabetes mellitus (GDM) in United Kingdom (UK) and Hong …

Background: Uncontrolled confounding from maternal depression and genetic and
environmental factors is expected in studies investigating the effect of prenatal …

Background: Routinely collected health data are increasingly used in clinical research. No
study has systematically reviewed the temporal trends in the number of publications and …

This study investigated whether antenatal exposure to antidepressants (ADs) increases the
risks of autism spectrum disorders (ASD), attention deficit/hyperactivity disorders (ADHD) …

Background Haloperidol remains a frequently prescribed first-generation antipsychotic.
However, haloperidol-associated mortality risk by all causes, cardiovascular disease (CVD) …

Prenatal antidepressant exposure has been reported to be associated with adverse
neurodevelopmental outcomes, yet studies considering confounding factors in Asian …

Background It is presumed that pharmacological and non-pharmacological treatment of
prenatal common mental disorders can mitigate associated adverse effects in offspring, yet …

Background Studies using data from Western countries have raised concerns that treating
pregnant women with antidepressants may increase the risk of autism spectrum disorders …

Aims Animal studies suggest that methylphenidate treatment for around 3 months may lead
to less mineralized and weaker appendicular bones. A systematic review was conducted to …